Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Aug 2:8:1425.
doi: 10.3389/fmicb.2017.01425. eCollection 2017.

The Exceptional Oncogenicity of HTLV-1

Yutaka Tagaya  1 , Robert C Gallo  1
Affiliations
Review

The Exceptional Oncogenicity of HTLV-1

Yutaka Tagaya et al. Front Microbiol. .

Abstract

Human T-cell leukemia virus-1 (HTLV-1) is the first pathogenic human retrovirus identified in 1979 by the Gallo group. HTLV-1 causes fatal T-cell leukemia (adult T cell leukemia) and a progressive myelopahy (HTLV-1-associated myelopathy/ tropical spastic paraparesis, HAM/TSP) and other disorders. Since the discovery of HTLV-1, several other microorganisms are demonstrated to cause cancer in humans. In this article, we investigated the oncogenic capacity of HTLV-1, in comparison with those of other oncoviruses and one oncobacterium (Helicobacter pylori, H. Pylori) based on published literature. We conclude here that HTLV-1 is one of the most and may be the most carcinogenic among them and arguably one of the most potent of the known human carcinogens. This fact has not been noted before and is particularly important to justify why we need to study HTLV-1 as an important model of human viral oncogenesis.

Keywords: HTLV-1; T-cell leukemia; oncogenicity; oncoviruses; retrovirus.

PubMed Disclaimer

References

    1. Bazarbachi A., Suarez F., Fields P., Hermine O. (2011). How i treat adult T-cell leukemia/lymphoma. Blood 118, 1736–1745. 10.1182/blood-2011-03-345702 - DOI - PubMed
    1. Becker J. C. (2010). Merkel cell carcinoma. Ann. Oncol. 21(Suppl. 7), vii81–vii85. 10.1093/annonc/mdq366 - DOI - PubMed
    1. Bhutani M., Polizzotto M. N., Uldrick T. S., Yarchoan R. (2015). Kaposi sarcoma-associated herpesvirus-associated malignancies: epidemiology, pathogenesis, and advances in treatment. Semin. Oncol. 42, 223–246. 10.1053/j.seminoncol.2014.12.027 - DOI - PMC - PubMed
    1. Epstein M. A., Achong B. G., Barr Y. M. (1964). Virus particles in cultured Lymphoblasts from Burkitt's Lymphoma. Lancet 1, 702–703. 10.1016/S0140-6736(64)91524-7 - DOI - PubMed
    1. Fattovich G., Bortolotti F., Donato F. (2008). Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J. Hepatol. 48, 335–352. 10.1016/j.jhep.2007.11.011 - DOI - PubMed

LinkOut - more resources